Ignite Creation Date:
2025-12-24 @ 6:39 PM
Ignite Modification Date:
2026-01-04 @ 5:23 AM
Study NCT ID:
NCT03552757
Status:
COMPLETED
Last Update Posted:
2021-11-09
First Post:
2018-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-04
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-30
First Submit QC Date:
None
Study First Post Date:
2018-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-16
Results First Submit QC Date:
None
Results First Post Date:
2021-08-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-08-11
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-11-08
Last Update Post Date:
2021-11-09
Last Update Post Date Type:
ACTUAL